Your browser doesn't support javascript.
loading
Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma.
Langendonk, Myra; Smit, Nienke A M; Plattel, Wouter; Diepstra, Arjan; Meerten, Tom van; Visser, Lydia.
Affiliation
  • Langendonk M; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
  • Smit NAM; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
  • Plattel W; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
  • Diepstra A; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
  • Meerten TV; Department of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
  • Visser L; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
Int J Mol Sci ; 23(22)2022 Nov 09.
Article in En | MEDLINE | ID: mdl-36430230
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hodgkin Disease / Antineoplastic Agents Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Type: Article Affiliation country: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hodgkin Disease / Antineoplastic Agents Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Type: Article Affiliation country: Netherlands